Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Protara Therapeutics Inc (NASDAQ: TARA) was $2.00 for the day, down -0.99% from the previous closing price of $2.02. In other words, the price has decreased by -$0.99 from its previous closing price. On the day, 0.15 million shares were traded. TARA stock price reached its highest trading level at $2.03 during the session, while it also had its lowest trading level at $1.9.
Ratios:
Our analysis of TARA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 16.33 and its Current Ratio is at 16.33. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.
On June 04, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $40.
On February 17, 2021, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $43.Oppenheimer initiated its Outperform rating on February 17, 2021, with a $43 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 16 ’24 when Opaleye Management Inc. sold 11,396 shares for $2.44 per share. The transaction valued at 27,828 led to the insider holds 56,500 shares of the business.
Opaleye Management Inc. sold 47,993 shares of TARA for $115,346 on Jul 11 ’24. The 10% Owner now owns 60,000 shares after completing the transaction at $2.40 per share. On Jul 10 ’24, another insider, Opaleye Management Inc., who serves as the 10% Owner of the company, sold 18,061 shares for $2.31 each. As a result, the insider received 41,685 and left with 75,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TARA now has a Market Capitalization of 41259600 and an Enterprise Value of -43337456.
Stock Price History:
Over the past 52 weeks, TARA has reached a high of $5.24, while it has fallen to a 52-week low of $1.04. The 50-Day Moving Average of the stock is -7.02%, while the 200-Day Moving Average is calculated to be -23.46%.
Shares Statistics:
TARA traded an average of 167.67K shares per day over the past three months and 179120 shares per day over the past ten days. A total of 20.63M shares are outstanding, with a floating share count of 18.51M. Insiders hold about 10.29% of the company’s shares, while institutions hold 46.39% stake in the company. Shares short for TARA as of 1723680000 were 1880102 with a Short Ratio of 11.21, compared to 1721001600 on 1800133. Therefore, it implies a Short% of Shares Outstanding of 1880102 and a Short% of Float of 12.1199995.
Earnings Estimates
The stock of Protara Therapeutics Inc (TARA) is currently being evaluated by 3.0 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is -$0.54, with high estimates of -$0.51 and low estimates of -$0.61.
Analysts are recommending an EPS of between -$2.22 and -$5.35 for the fiscal current year, implying an average EPS of -$3.06. EPS for the following year is -$3.2, with 4.0 analysts recommending between -$1.54 and -$5.95.
